We are pleased to announce that Prof. Dr. Kristina Friedland and Dr. Selin Akpinar Adscheid are participating in GeneNovate, Germany’s flagship entrepreneurship program focused on gene and cell therapies, biotechnology, medicine, and the life sciences.

GeneNovate is Germany’s first nationwide entrepreneurship program dedicated to innovation in gene and cell therapies, biotechnology, medicine, and the life sciences. The initiative empowers early-career researchers and experienced investigators to translate scientific discoveries into impactful ventures. Through interdisciplinary teams, GeneNovate offers hands-on workshops, expert mentoring, and practice-oriented training, addressing key aspects such as value proposition development, translational strategy, funding pathways, and investor pitching.